$30.61
-0.04 (-0.13%)
ViroPharma, Inc. (NASDAQ:VPHM)
CAPS Rating:
A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.
RSS Headlines
Fool UK